RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase = TLD-1433
And meanwhile, back at the ranch, closed Friday at $4.64, opened today at $20 hit a high of $33 and closed at $22:
Shares of Seres Therapeutics Inc.(MCRB) rocketed nearly fourfold (up 270%) on heavy volume in premarket trading Monday, after the microbiome therapeutics company reported upbeat results of a Phase 3 trial of its SER-109 for recurrent C. difficile infections (CDI), or an infection of the colon.